News
TSBX
0.3550
0.00%
0.0000
XOMA Royalty Corporation Completes Acquisition of Turnstone Biologics Corp
Reuters · 08/15/2025 20:01
Turnstone Biologics Updates Corporate Governance Structure
TipRanks · 08/11/2025 14:57
Turnstone Biologics Corp. Announces Delisting from Nasdaq Following Merger Completion
Reuters · 08/11/2025 14:31
Xoma closes tender offer for Turnstone Biologics
TipRanks · 08/11/2025 13:10
XOMA ROYALTY ANNOUNCES CLOSING OF TENDER OFFER FOR TURNSTONE BIOLOGICS
Reuters · 08/11/2025 13:00
Weekly Report: what happened at TSBX last week (0804-0808)?
Weekly Report · 08/11/2025 10:59
Weekly Report: what happened at TSBX last week (0728-0801)?
Weekly Report · 08/04/2025 11:01
Weekly Report: what happened at TSBX last week (0721-0725)?
Weekly Report · 07/28/2025 11:03
Weekly Report: what happened at TSBX last week (0714-0718)?
Weekly Report · 07/21/2025 10:53
Weekly Report: what happened at TSBX last week (0707-0711)?
Weekly Report · 07/14/2025 11:01
Weekly Report: what happened at TSBX last week (0630-0704)?
Weekly Report · 07/07/2025 10:54
Weekly Report: what happened at TSBX last week (0623-0627)?
Weekly Report · 06/30/2025 11:00
Turnstone Biologics Corp. Enters Merger Agreement with XOMA
TipRanks · 06/27/2025 20:50
XOMA Royalty To Acquire Turnstone Biologics
NASDAQ · 06/27/2025 12:13
Turnstone Biologics to be acquired by XOMA Royalty
Seeking Alpha · 06/27/2025 12:00
XOMA Royalty to Buy Turnstone Biologics
Dow Jones · 06/27/2025 11:56
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
TipRanks · 06/27/2025 11:40
XOMA Royalty To Acquire Turnstone Biologics For $0.34 Per Share Plus CVR In August-Targeted Merger Deal
Benzinga · 06/27/2025 11:33
TURNSTONE BIOLOGICS CORP - DEAL VALUED AT $0.34 PER SHARE PLUS CVR
Reuters · 06/27/2025 11:30
TSBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Turnstone Biologics Corp. Is Fair to Shareholders
Barchart · 06/27/2025 08:19
More
Webull provides a variety of real-time TSBX stock news. You can receive the latest news about Turnstone Biologics Corp through multiple platforms. This information may help you make smarter investment decisions.
About TSBX
Turnstone Biologics Corp. is a biotechnology company. The Company has been focused on the development of a differentiated approach to treating and curing patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy. It has discontinued all sponsored clinical studies evaluating TIDAL-01 for all indications, and pursuit of strategic alternatives to enhance and preserve stockholder value, which may include exploration and evaluation of strategic options like a merger, reverse merger, other business combinations, sale of assets, licensing, or other strategic transactions.